Tamponades is fastest growing segment fueling the growth of the Global Vitreous Tamponades Market
The
global Vitreous Tamponades Market is estimated to be valued at US$ 83.89 Mn in
2023 and is expected to exhibit a CAGR of 2.5% over the forecast period
2023-2030, as highlighted in a new report published by Coherent Market
Insights.
Market Overview: Vitreous tamponades
are substances used to seal retinal breaks and provide internal tamponade
during vitrectomy surgeries. They help stabilize the retina and promote
posterior vitreous detachment. The different types of tamponades include gases,
silicone oils and perfluoro-n-octane.
Market key trends: One of the key
trends in the market is the preference for non-silicone tamponades over
traditional silicone oils. Silicone oils have been commonly used but are
difficult to remove and can cause complications. Newer tamponades such as
perfluorocarbon liquids and gases provide effective internal tamponade with
better removal properties. They minimize complications and improve surgical
outcomes leading to their increased demand.
Segment Analysis
The global vitreous
tamponades market is segmented based on tamponade type and end use.
Based on type, the market is segmented into gas tamponades, silicone oil
tamponades and perfluoropropane tamponades. Among these, silicone oil
tamponades dominate the market due to their widespread adoption for retinal
reattachment surgeries. Silicone oils offer long-term effectiveness and are
highly biocompatible.
Key Takeaways
The global vitreous tamponades market is expected to witness high growth,
exhibiting a CAGR of 2.5% over the forecast period, due to increasing
prevalence of retinal detachment cases.
Market size related content comprises:
The global vitreous tamponades market is expected to witness high growth,
exhibiting a CAGR of 2.5% over the forecast period, due to increasing
prevalence of retinal detachment cases. The market was valued at US$ 83.89 Mn
in 2023 and is anticipated to reach US$ 94.11 Mn by 2030.
Regional analysis related content
comprises: North America dominated the global vitreous tamponades market in
2023 and is expected to continue its dominance over the forecast period. This
is attributed to presence of advanced healthcare facilities and growing
adoption of effective retinal tamponading agents in vitreoretinal surgeries
within the region.
Key players related content comprises:
Key players operating in the vitreous tamponades market are Alchimia srl,
Alcon, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Croma-Pharma
GmbH, Dutch Ophthalmic Research Center (International) B.V., and Fluoron GmbH.
Comments
Post a Comment